Sectors

ELV
Elevance Health, Inc.
300.74
160 x 301.00
200 x 300.79
bid
ask
+
2.24
0.75%
180 @ 04:00 PM
300.06 -0.68 (0.23%)
Ytd -14.21%
1y -29.95%
294.89
day range
302.94
274.66
52 week range
452.69
Open 295.24 Prev Close 298.50 Low 294.89 High 302.94 Mkt Cap 66.37B
Vol 984.81K Avg Vol 1.93M EPS 25.20 P/E 11.93 Forward P/E 10.22
Beta 0.47 Short Ratio 1.57 Inst. Own 94.02% Dividend 6.88 Div Yield 2.30
Ex Div Date 03-10 Earning 04-22 50-d Avg 316.64 200-d Avg 327.86 1yr Est 380.95
Earning
Date For Estimate Reported Surprise surprise %
2026-04-22 2026-03 10.61 N/A N/A N/A
2026-01-28 2025-12 3.11 3.33 0.22 7.07%
2025-10-21 2025-09 4.98 6.03 1.05 21.08%
2025-07-17 2025-06 9.16 8.84 -0.32 -3.49%
2025-04-22 2025-03 11.21 11.97 0.76 6.78%
2025-01-23 2024-12 3.8 3.84 0.04 1.05%
Upgrade / Downgrade
Date Firm Action From To
2026-03-11 Mizuho Upgrade Outperform Outperform
2026-02-02 JP Morgan Upgrade Overweight Overweight
2026-02-02 Truist Securities Upgrade Buy Buy
2026-01-30 Barclays Upgrade Overweight Overweight
2026-01-30 Wells Fargo Upgrade Overweight Overweight
2026-01-29 Guggenheim Upgrade Buy Buy
Profile
Elevance Health, Inc., together with its subsidiaries, operates as a health benefits company in the United States. The company operates in four segments: Health Benefits, CarelonRx, Carelon Services, and Corporate & Other. It offers a variety of health plans and services to individual, employer group risk-based and fee-based, BlueCard, Medicare, Medicaid, and FEP members; health products; a broad array of fee-based administrative managed care services; and specialty and other insurance products and services, such as stop loss, dental, vision, and supplemental health insurance benefits. The company also operates in the pharmacy services business; and markets and offers pharmacy services, including home delivery and specialty pharmacies, claims adjudication, formulary management, pharmacy networks, rebate administration, a prescription drug database, and member services, as well as infusion services and injectable therapies through ambulatory infusion centers. In addition, it provides healthcare related services and capabilities, including specialty care enablement and utilization management support for specialized clinical domains; behavioral health and comprehensive care management services; palliative care services and management; virtual care; and payment integrity, subrogation, clinical data exchange through its HealthOS platform, research and data, reporting and clinical analytics, information technology, and business process support services, as well as manages home health, post-acute institutional management, and durable medical equipment costs; and supports plans in managing home and community-based services. The company provides its services under the Anthem Blue Cross and Blue Shield, Wellpoint, and Carelon brands. The company was formerly known as Anthem, Inc. and changed its name to Elevance Health, Inc. in June 2022. Elevance Health, Inc. was incorporated in 2001 and is based in Indianapolis, Indiana.
Insider Holder
Date Name Relation Quantity Description
2025-07-17 BOUDREAUX GAIL A KOZIARA Chief Executive Officer 151.08K Purchase
2026-03-01 BOUDREAUX GAIL KOZIARA Chief Executive Officer 169.31K Stock Award(Grant)
2025-05-13 DIXON ROBERT L JR Director 10.32K Stock Award(Grant)
2025-05-13 HAY LEWIS III Director 11.51K Stock Award(Grant)
2026-03-01 HAYTAIAN PETER D Officer 27.22K Stock Award(Grant)
2026-03-01 KAYE MARK Chief Financial Officer 32.04K Stock Award(Grant)
Institution Ownership
Report Date Organization Position Value Percentage
2025-12-30 Vanguard Group Inc 23.02M 6.92B 10.48%
2025-12-30 Blackrock Inc. 20.40M 6.14B 9.29%
2025-12-30 State Street Corporation 10.34M 3.11B 4.71%
2025-12-30 Wellington Management Group, LLP 8.29M 2.49B 3.77%
2025-12-30 Price (T.Rowe) Associates Inc 7.45M 2.24B 3.39%
2025-12-30 Sanders Capital, LLC 5.75M 1.73B 2.62%
Fund Ownership
Report Date Organization Position Value Percentage
2025-12-30 VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund 6.99M 2.10B 3.18%
2025-12-30 VANGUARD INDEX FUNDS-Vanguard 500 Index Fund 5.60M 1.69B 2.55%
2026-01-30 VANGUARD WINDSOR FUNDS-Vanguard Windsor II Fund 3.07M 922.13M 1.40%
2026-01-30 iShares Trust-iShares Core S&P 500 ETF 2.86M 860.07M 1.30%
2026-01-30 First Eagle Funds-First Eagle Global Fund 2.84M 855.57M 1.30%
2026-02-27 Fidelity Concord Street Trust-Fidelity 500 Index Fund 2.83M 850.57M 1.29%
Dividend
Dividend Date
1.72 2026-03-10
1.71 2025-12-05
1.71 2025-09-10
1.71 2025-06-10
1.71 2025-03-10
1.63 2024-12-05
Split
Split Date
2 : 1 2005-06-01